Eastern Bank’s Corbus Pharmaceuticals CRBP Stock Holding History

Eastern Bank’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$41	Hold	6	–	–	﹤0.01%	1101
2026 Q2	$56	Hold	6	–	–	﹤0.01%	1030
2026 Q1	$56	Hold	6	–	–	﹤0.01%	1064
2025 Q4	$49	Hold	6	–	–	﹤0.01%	1158
2025 Q3	$76	Hold	6	–	–	﹤0.01%	1001
2025 Q2	$41	Hold	6	–	–	﹤0.01%	923
2025 Q1	$32	Buy	+6	New	+$53	﹤0.01%	980

Other funds holding CRBP

Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Eastern Bank's CRBP Position: Q3 2026 in Review

Eastern Bank held its Corbus Pharmaceuticals (CRBP) position steady in Q3 2026 at 6 shares worth $41. The position accounts for ﹤0.01% of the portfolio, ranked #1101.

Eastern Bank first reported a position in CRBP in Q1 2025 and has held it in 7 quarters since. The position peaked at $76 in Q3 2025. 6 funds tracked by Wall St. Rank hold CRBP as of Q3 2026.

Eastern Bank held 6 shares of Corbus Pharmaceuticals worth $41 as of Q3 2026.
Eastern Bank left its Corbus Pharmaceuticals share count unchanged in Q3 2026.
Corbus Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #1101 holding.
Eastern Bank first reported a position in Corbus Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
Eastern Bank's Corbus Pharmaceuticals position peaked at $76 in Q3 2025.
6 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.